Dr. Christin Glorioso is a neuroscientist, physician, and serial entrepreneur. She is Co-Founder and CEO of NeuroAge Therapeutics and Founder and Executive Director of the non-profit, Longevity Global. Previously she was Head of AI of the Stanford Spinout, TeachAids. She has published more than 30 peer reviewed publications and been awarded grants by AFAR, the Glenn Foundation for Medical Research, and the National Institute on Aging. Dr. Glorioso holds an MD and PhD in Neuroscience from the University of Pittsburgh and Carnegie Mellon University’s Medical Scientist Training Program and completed her postdoctoral training at MIT.